A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor	Advanced Liver Cancer	Recruiting	Phase 1	2026-04-07		NCT04906434

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Abbisko Therapeutics Co, Ltd	22

32 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Tsinghua Changgung Hospital	Beijing	China	10
Chongqing Cancer Hospital	Chongqing	China	6
First Affiliated Hospital of Henan University of Science and Technology	Luoyang	China	2
Fujian Provincial Cancer Hospital	Fuzhou	China	10
General Hospital of Ningxia Medical University	Yinchuan	China	24
Guangxi Zhuang Autonomous Region People's Hospital	Nanning	China	4
Harbin Medical University Cancer Hospital	Haerbin	China	3
Henan Cancer Hospital	Zhengzhou	China	98
Hubei Cancer Hospital	Wuhan	China	32
Hunan Cancer Hospital	Changsha	China	87
Hunan Provincial People's Hospital	Changsha	China	16
Icahn School of Medicine at Mount Sinai	New York	United States	342
Jinan Central Hospital	Jinan	China	24
Linyi Cancer Hospital	Linyi	China	22
Mayo Clinic	Rochester	United States	664
Mayo Clinic	Phoenix	United States	50
Mayo Clinic	Jacksonville	United States	122
MD Anderson Cancer Center	Houston	United States	589
Mianyang Central Hospital	Mianyang	China	9
Moffitt Cancer Center	Tampa	United States	523
Nation Taiwan University Hospital	Taipei	Taiwan	1
National Cheng Kung University Hospitals	Tainan	Taiwan	1
Ningbo Huamei Hospital, University of Chinese Academy of Sciences	Ningbo	China	1
Shengjing Hospital of China Medical University	Shenyang	China	32
Sun Yat Sen Memorial Hospital	Guangzhou	China	1

Clinical trials